Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WID-RGC20 (Cariprazine) in Acute Schizophrenia
NCT05168007Phase 3Unknown
- Sponsor
- WhanIn Pharm
- Start
- Nov 2021
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of cariprazine in schizophrenia, sponsored by WhanIn Pharm. Status: unknown.
02
Drugs
cariprazine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT05168007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05168007.